Dr Amir criticises argument for not taking coronavirus vaccine When you subscribe we will use the information you provide to
Professor Van-Tam unsure on the efficacy of vaccines against new variants
Purely mathematical perspective on delaying the second dose of the SARS-CoV-2 vaccine
The three most popularly administered severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines developed so far (Pfizer, Oxford/AstraZeneca, and Moderna)
Experts outline key challenges for assessing clinical efficacy of COVID-19 vaccines
Collaboration and standardised approaches for assessing different vaccine efficacy endpoints are key for meaningful comparison of different COVID-19 vaccine candidates